These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7695232)

  • 81. Down-regulation of striatal enkephalinergic (PPA) messenger RNA without prior apoptotic features following reversible focal ischemia in rat.
    Popovici T; Margaill I; Plotkine M; Ben-Ari Y; Charriaut-Marlangue C
    Brain Res; 1997 Jan; 744(1):185-7. PubMed ID: 9030432
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Selective defect of in vivo glycolysis in early Huntington's disease striatum.
    Powers WJ; Videen TO; Markham J; McGee-Minnich L; Antenor-Dorsey JV; Hershey T; Perlmutter JS
    Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2945-9. PubMed ID: 17299049
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Synthetic lethal screening in the mammalian central nervous system identifies Gpx6 as a modulator of Huntington's disease.
    Shema R; Kulicke R; Cowley GS; Stein R; Root DE; Heiman M
    Proc Natl Acad Sci U S A; 2015 Jan; 112(1):268-72. PubMed ID: 25535386
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Increased preproenkephalin mRNA and preprotachykinin mRNA in the striatum of Rolling mouse Nagoya.
    Taniwaki T; Shinoda H; Kaseda Y; Kato M; Goto I
    Brain Res; 1996 Apr; 714(1-2):231-4. PubMed ID: 8861630
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease.
    Peschanski M; Cesaro P; Hantraye P
    Neuroscience; 1995 Sep; 68(2):273-85. PubMed ID: 7477940
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Parasynaptic corpora amylacea in the striatum.
    Averback P
    Arch Pathol Lab Med; 1981 Jun; 105(6):334-5. PubMed ID: 6453566
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Reduction in the ratio of beta-preprotachykinin to preproenkephalin messenger RNA expression in postmortem human putamen during aging and in patients with status lacunaris. Implications for the susceptibility to parkinsonism.
    Tohgi H; Utsugisawa K; Yoshimura M; Yamagata M; Nagane Y; Saitoh K
    Brain Res; 1997 Sep; 768(1-2):86-90. PubMed ID: 9369304
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Metabolic changes in the basal ganglia of patients with Huntington's disease: an in situ hybridization study of cytochrome oxidase subunit I mRNA.
    Gourfinkel-An I; Vila M; Faucheux B; Duyckaerts C; Viallet F; Hauw JJ; Brice A; Agid Y; Hirsch EC
    J Neurochem; 2002 Feb; 80(3):466-76. PubMed ID: 11905993
    [TBL] [Abstract][Full Text] [Related]  

  • 89. C-Fos proteins are not involved in the activation of preproenkephalin gene expression in rat brain by peripheral electric stimulation (electroacupuncture).
    Guo HF; Cui X; Hou Y; Tian J; Wang X; Han J
    Neurosci Lett; 1996 Apr; 207(3):163-6. PubMed ID: 8728475
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Preproenkephalin gene expression in the rat cerebral cortex during chronic tracheal stenosis.
    Aoki M; Kikuchi Y; Abe K; Kurosawa H; Ogawa H; Mizusawa A; Hida W
    Neurol Res; 1994 Jun; 16(3):213-6. PubMed ID: 7523976
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Study of the non-inflammatory lesions of neurosyphilis. 3. Case of progressive paralysis association with Huntington's chorea].
    Matsuoka T; Miyoshi K; Saka K
    No To Shinkei; 1968; 20(9):925-30. PubMed ID: 4180783
    [No Abstract]   [Full Text] [Related]  

  • 92. A note on experimental approaches to Huntington's disease.
    Roberts E; Goetz I; Comings DE
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():331-6. PubMed ID: 137503
    [No Abstract]   [Full Text] [Related]  

  • 93. Decrease in a proenkephalin peptide in cerebrospinal fluid in Huntington's disease and progressive supranuclear palsy.
    Iadarola MJ; Mouradian MM
    Brain Res; 1989 Feb; 479(2):397-401. PubMed ID: 2522341
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The selective vulnerability of striatopallidal neurons.
    Mitchell IJ; Cooper AJ; Griffiths MR
    Prog Neurobiol; 1999 Dec; 59(6):691-719. PubMed ID: 10845758
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Preproenkephalin mRNA expression in nucleus caudalis neurons is enhanced by trigeminal stimulation.
    Nishimori T; Buzzi MG; Moskowitz MA; Uhl GR
    Brain Res Mol Brain Res; 1989 Nov; 6(2-3):203-10. PubMed ID: 2615596
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The autocrine derivation of the opioid growth factor, [Met5]-enkephalin, in ocular surface epithelium.
    Zagon IS; Sassani JW; Wu Y; McLaughlin PJ
    Brain Res; 1998 May; 792(1):72-8. PubMed ID: 9593829
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Altered thyrotropic and lactotropic axes regulation in Huntington's disease.
    Aziz NA; Pijl H; Frölich M; Roelfsema F; Roos RA
    Clin Endocrinol (Oxf); 2010 Oct; 73(4):540-5. PubMed ID: 20550529
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Huntington's disease gene (IT15) is widely expressed in human and rat tissues.
    Li SH; Schilling G; Young WS; Li XJ; Margolis RL; Stine OC; Wagster MV; Abbott MH; Franz ML; Ranen NG
    Neuron; 1993 Nov; 11(5):985-93. PubMed ID: 8240819
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Nerve cell loss in the thalamic centromedian-parafascicular complex in patients with Huntington's disease.
    Heinsen H; Rüb U; Gangnus D; Jungkunz G; Bauer M; Ulmar G; Bethke B; Schüler M; Böcker F; Eisenmenger W; Götz M; Strik M
    Acta Neuropathol; 1996; 91(2):161-8. PubMed ID: 8787149
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The use of in situ hybridization histochemistry for the study of neuropeptide gene expression in the human brain.
    Mengod G; Charli JL; Palacios JM
    Cell Mol Neurobiol; 1990 Mar; 10(1):113-26. PubMed ID: 2334944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.